EFFECT OF GROWTH-HORMONE REPLACEMENT ON BONE MASS IN ADULTS WITH ADULT-ONSET GROWTH-HORMONE DEFICIENCY

被引：84

作者：

HOLMES, SJ

WHITEHOUSE, RW

SWINDELL, R

ECONOMOU, G

ADAMS, JE

SHALET, SM

机构：

[1] CHRISTIE HOSP NHS TRUST,DEPT ENDOCRINOL,MANCHESTER M20 4BX,LANCS,ENGLAND

[2] CHRISTIE HOSP NHS TRUST,DEPT MED STAT,MANCHESTER M20 4BX,LANCS,ENGLAND

[3] UNIV MANCHESTER,DEPT DIAGNOST RADIOL,MANCHESTER M13 9PT,LANCS,ENGLAND

来源：

CLINICAL ENDOCRINOLOGY | 1995年 / 42卷 / 06期

关键词：

D O I：

10.1111/j.1365-2265.1995.tb02690.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVE Previous studies of the effect of GH replacement on bone mass In adults with GH deficiency have produced conflicting results. We have studied the effect of 6 and 12 months of GH replacement on bone mass in adults with adult onset GH deficiency. DESIGN Double blind placebo controlled study of GH replacement (0.125 IU/kg/week for the first month and 0.25 IU/kg/week thereafter) for 6 months and an open study for a further 6 or 12 months. PATIENTS Twenty-two adults (10 men, 12 women), aged 41.5 +/- 2.1 years (mean +/- SE, range 23.6-59.5), with adult onset GH deficiency. MEASUREMENTS Single-energy quantitative computed tomography was used to measure vertebral trabecular bone mineral density (BMD), single-photon absorptiometry (SPA) was used to measure forearm cortical and integral bane mineral content and BMD and dual-energy X-ray absorptiometry (DXA) was used to measure lumbar spine, femoral neck, trochanteric and Ward's triangle integral BMD. RESULTS After 6 months of GH replacement (n = 21) there was a significant decrease in forearm cortical BMD (SPA: median change -0.009 g/cm(2), P=0.01), forearm integral BMD (SPA: median change -0.016 g/cm(2), P=0.03), lumbar spine BMD (DXA: median change -0.022 g/cm(2); P=0.003) and femoral neck BMD (DXA: median change -0.029 g/cm(2), P=0.006). After 12 months of GH replacement (n = 13) there was a significant decrease in lumbar spine BMD (DXA: median change -.0035 g/cm(2), P=0.002) from baseline. There was no significant increase in bone mass at any site after 6 or 12 months of GH replacement. Change in bone mass was not influenced by sex of the patient or by presence or absence of additional pituitary hormone deficiencies. CONCLUSION The response of bone mass to 6 and 12 months of GH replacement in adults with adult onset GH deficiency is disappointing. Longer-term studies are required to determine whether prolonged GH replacement has a beneficial effect on bone mass.

引用

页码：627 / 633

页数：7

共 28 条

[1] Adams J.E., Adams P.H., The measurement of spinal bone mass by quantitative computed tomography: assessment of precision and different calibration phantoms, British Journal of Radiology, 61, (1988)
[2] Amato A., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., Marciano-Mone C., Sacca L., Bellastella A., Body composition, bone metabolism, and heart structure and function in growth hormone (GH)‐deficient adults before and after GH replacement therapy at low doses, Journal of Clinical Endocrinology and Metabolism, 77, pp. 1671-1676, (1993)
[3] Baum H.B.A., Biller B.M.K., Baker K.E., Klibanski A., Physiologic growth hormone (GH) replacement improves body composition and bone density in men with adult‐onset GH‐deficiency, (1994)
[4] Beshyah S.A., Thomas E., Kyd P., Sharp P., Fairney A., Johnston D.G., The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism, Clinical Endocrinology, 40, pp. 383-391, (1994)
[5] Bing-You R.G., Denis M.-C., Rosen C.J., Low bone mineral density in adults with previous hypothalamic‐pituitary tumours: correlations with serum growth hormone responses to GH‐releasing hormone, insulin‐like growth factor I, and IGF binding protein 3, Calcified Tissue International, 52, pp. 183-187, (1993)
[6] Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A.P., Birkenhager J.C., Lamberts S.W.J., The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition, Clinical Endocrinology, 37, pp. 79-87, (1992)
[7] Cann C.E., Genant H.K., Precise measurement of vertebral mineral content using computed tomography, Journal of Computer Assisted Tomography, 4, pp. 493-500, (1980)
[8] Cullum I.D., Ell P.J., Ryder J.P., X‐ray dual‐photon absorptiometry: a new method for the measurement of bone density, British Journal of Radiology, 62, pp. 587-592, (1989)
[9] De Boer H., Blok G.J., Van Lingen A.V., Teule G.J.J., Lips P., Van Der Veen E.A., Consequences of childhood‐onset growth hormone deficiency for adult bone mass, Journal of Bone and Mineral Research, 9, pp. 1319-1326, (1984)
[10] Degerblad M., Almkvist O., Grunditz R., Hall K., Kaijser L., Knutsson E., Ringertz H., Thoren M., Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency, Acta Endocrinologica, 123, pp. 185-193, (1990)

← 1 2 3 →